NCT05975255View on ClinicalTrials.gov

Dose Finding Study for Remimazolam in Children

PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 16, 2023

Primary Completion Date

October 31, 2024

Study Completion Date

December 31, 2024

Conditions
Drug Effect
Interventions
DRUG

Remimazolam besylate

Intravenous administration of predetermined dose of Byfavo for 30 seconds

Trial Locations (1)

03080

RECRUITING

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER